Research in Pitt-Hopkins at Sant Joan de Déu, a neurodevelopmental disorder
Dr. Judith Armstrong initiates a project to understand why patients with mutations in different genes present the same clinical features as Rett syndrome.
-
International travel affects gut microbiota
A collaborative study between the Institut de Recerca Sant Joan de Déu (IRSJD) and the Institut d'Investigació i Innovació Parc Taulí (I3PT) demonstrates that traveling and being exposed to new people, traditions, cultures, and unfamiliar foods can change gut microbiota and its diversity.
-
A Predictive Tool for Personalizing Psychosis Treatment
Dr. Susana Ochoa from the Sant Joan de Déu Research Institute · Parc Sanitari Sant Joan de Déu leads a European project to offer personalized metacognitive training for people with psychosis by developing a learning algorithm.
-
A potential therapeutic target has been discovered for the rare metabolic disease PMM2-CDG
The collaboration of three research groups has made it possible to identify cellular and molecular pathways affected in patients with PMM2-CDG through the development of a transcriptomic data analysis technology using patient-derived fibroblasts.
-
New discoveries about the EWS-FLI oncogene involved in the development of Ewing's tumor
Researchers from IRSJD · SJD Barcelona Children’s Hospital and IRB Barcelona have successfully developed Drosophila models expressing the EWS-FLI oncogene at varying levels, overcoming previous toxicity challenges and enabling detailed study of Ewing sarcoma's oncogenic pathways.
-
Preg-MEDAS questionnaire: questions for a healthier pregnancy
A study conducted by IRSJD and IDIBAPS introduces the new preg-MEDAS questionnaire, which measures the positive impact of the Mediterranean diet on pregnant women. The study demonstrated that women following the Mediterranean diet significantly reduced their blood pressure.
-
New Therapeutic Targets to Fight Type 2 Diabetes
A study led by Dr Manuel Vázquez-Carreras presents an integrative view of the most outstanding advances in understanding this process and helping to identify new pharmacological targets in the fight against type 2 diabetes mellitus.
-
Automated learning app improves accessibility to medulloblastoma classification
A team from the Sant Joan de Déu Research Institute, Sant Joan de Déu Hospital, and the Polytechnic University of Catalonia, has developed an artificial intelligence-based application to make the classification of medulloblastoma subgroups more accessible, less costly, and faster
-
The first living pediatric patients brain tissue laboratory in Europe
King's College London and Sant Joan de Déu have formalized an agreement to develop a new living pediatric patients brain pediatric tissue laboratory. The laboratory is set to open at the beginning of 2025 and will be led by Dr. Óscar Marín, a neuroscience expert.
